Abstract:Abstract Autophagy is an evolutionarily conserved process whereby cells catabolize damaged proteins and organelles for purposes of generating substrates for sustaining ATP production during times of nutrient deprivation. This self-eating process is associated with many diseases, particular in cancers. The theory remains controversial due to limitation of the assays about autophagy, which requires specific assays and further studies to reevaluate the role of autophagy on cancer cells. Autophagins/Atg4 are a class of cytosolic cysteine proteases and play dual roles in autophagy machinery, suggesting tightly control of Atg4 is critical for regulation of autophagy. There are four human genes encoding Atg4 (Atg4A, Atg4B, Atg4C, Atg4D). Among them, Atg4B appears functional dominance in regulation of autophagy. Knocking down Atg4B or overexpression of catalytic mutant of Atg4B inhibited cell growth in various cancer cells. Moreover, Atg4B reveals three phosphorylation sites at Ser 316, 383, 392 in cells through large-scale phosphoproteomics approach. Inhibiting phosphorylation of Atg4B diminished proteolysis activity both in vitro and in cells, suggesting kinases may serve as activators for Atg4B. Further, we employed mammalian cell-based Atg4B assay to screen potential kinases activators of Atg4B with kinome siRNA library, which consists 704 kinase related genes. Twelve hits were reproducible and reconfirmed with GFP-LC3 stably expressed cells as a secondary assay. Four kinase hits were interacted with Atg4B and showed same effect on GFP-LC3 cleavage. Knocking down kinase hits diminished Atg4B proteolysis activity and cell growth in cancer cells, demonstrating novel function of the kinase hits on Atg4B-mediated autophagy and cancer growth. Our finding may provide new kinases as biomarkers or drug targets for cancer therapy. Citation Format: Chih-Wen Shu, Pei-Feng Liu, John C. Reed. High throughput screening kinase activators of Atg4B for cancer therapy. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr LB-128. doi:10.1158/1538-7445.AM2013-LB-128 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Targeting Atg4B for cancer therapy: Chemical mediators

Targeting ATG4 in Cancer Therapy

Unraveling the roles of Atg4 proteases from autophagy modulation to targeted cancer therapy.

Discovery of a small molecule targeting autophagy via ATG4B inhibition and cell death of colorectal cancer cells in vitro and in vivo.

Ablation of ATG4B Suppressed Autophagy and Activated AMPK for Cell Cycle Arrest in Cancer Cells

New Anti-Cancer Strategy to Suppress Colorectal Cancer Growth Through Inhibition of ATG4B and Lysosome Function

The regulatory factors and pathological roles of autophagy-related protein 4 in diverse diseases: Recent research advances

Autophagic Pathways As New Targets for Cancer Drug Development

Unravelling the multifaceted roles of Atg proteins to improve cancer therapy.

Abstract LB-128: High Throughput Screening Kinase Activators of Atg4B for Cancer Therapy.

Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Autophagy in Glioblastoma

Autophagy Regulators As Potential Cancer Therapeutic Agents: A Review

Untangling knots between autophagic targets and candidate drugs, in cancer therapy.

Synthesis and Structural Optimization of ATG4B Inhibitors for the Attenuation of Treatment-Induced Autophagy in Glioblastoma

Systems biology-based discovery of a potential Atg4B agonist (Flubendazole) that induces autophagy in breast cancer

Targeting Autophagy Peptidase ATG4B with a Novel Natural Product Inhibitor Azalomycin F4a for Advanced Gastric Cancer

Novel Atg4B Inhibitors Potentiate Cisplatin Therapy in Lung Cancer Cells Through Blockade of Autophagy

Key Autophagic Targets and Relevant Small-Molecule Compounds in Cancer Therapy.

Targeting Autophagy with Natural Compounds in Cancer: A Renewed Perspective from Molecular Mechanisms to Targeted Therapy

ATG4B and pS383/392-ATG4B serve as potential biomarkers and therapeutic targets of colorectal cancer

Cell-Based Drug Screening for Inhibitors of Autophagy Related 4B Cysteine Peptidase.